Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

NCT05001880 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

NIH

Sponsor class

Conditions

Peritoneal Malignant Mesothelioma

Interventions

BIOLOGICAL: Atezolizumab
BIOLOGICAL: Bevacizumab
PROCEDURE: Biospecimen Collection
DRUG: Carboplatin
PROCEDURE: Computed Tomography
PROCEDURE: Cytoreductive Surgery
DRUG: Hyperthermic Intraperitoneal Chemotherapy
DRUG: Pemetrexed
PROCEDURE: Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)